COVID-19 vaccination and the right to take risks
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
- Covid-19: Risk of cerebral blood clots from disease is 10 times that from vaccination, study finds
- Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study
- Balancing benefits and potential risks of vaccination: the precautionary principle and the law of unintended consequences
- Healthcare workers’ perceptions and attitudes towards the UK’s COVID-19 vaccination programme: a rapid qualitative appraisal
- What is the extent of COVID-19 vaccine hesitancy in Bangladesh? A cross-sectional rapid national survey
- The UPTAKE study: a cross-sectional survey examining the insights and beliefs of the UK population on COVID-19 vaccine uptake and hesitancy
- Covid-19: How AstraZeneca lost the vaccine PR war
- Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
- Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study